Kontrazeption, Fertilität und Fertilitätsprotektion bei Transpersonen unter geschlechtsangleichender Hormontherapie

• Literatur

• 1 Reynolds CA, Charlton BM.. Sexual Behavior and Contraceptive Use Among Cisgender and Gender Minority College Students Who Were Assigned Female at Birth. J Pediatr Adolesc Gynecol 2021; 34: 477-483
• 2 Berglin M. et al. Intrauterine device, subdermal contraceptive, and depot medroxyprogesterone use among transmasculine and cisgender patients over a 10-year period. Contraception 2022; 108: 56-60
• 3 Stark B. et al. The contraceptive and reproductive history and planning goals of trans-masculine adults: a mixed-methods study. Contraception 2019; 100: 468-473
• 4 Kanj RV. et al. Hormonal contraceptive choices in a clinic-based series of transgender adolescents and young adults. Int J Transgend 2019; 20: 413-420
• 5 Yaish I. et al. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment. Hum Reprod 2021; 36: 2753-2760
• 6 De Roo C. et al. Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment. Reprod Biomed Online 2017; 34: 557-566
• 7 Borrás A. et al. Endocrinological and ovarian histological investigations in assigned female at birth transgender people undergoing testosterone therapy. Reprod Biomed Online 2021; 43: 289-297
• 8 Marschalek J. et al. Markers of vitality in ovaries of transmen after long-term androgen treatment: a prospective cohort study. Mol Med 2020; 26: 83
• 9 Taub RL. et al. The effect of testosterone on ovulatory function in transmasculine individuals. Am J Obstet Gynecol 2020; 223: 229.e1-229.e8
• 10 de Nie I. et al. Impaired semen quality in trans women: prevalence and determinants. Hum Reprod 2020; 35: 1529-1536
• 11 de Nie I. et al. A cohort study on factors impairing semen quality in transgender women. Am J Obstet Gynecol 2022; 226: 390.e1-390.e10
• 12 Rodriguez-Wallberg KA. et al. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study. Andrology 2021; 9: 1773-1780
• 13 Marsh C. et al. Low total motile sperm in transgender women seeking hormone therapy. J Assist Reprod Genet 2019; 36: 1639-1648
• 14 Barda S. et al. Sperm parameters in Israeli transgender women before and after cryopreservation. Andrology 2022;
• 15 Amir H. et al. Adolescent Transgender Females Present Impaired Semen Quality That Is Suitable for Intracytoplasmic Sperm Injection Even Before Initiating Gender-Affirming Hormone Treatment. Reprod Sci 2022; 29: 260-269
• 16 de Nie I. et al. Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women. Hum Reprod 2022; 37: 297-308
• 17 Adeleye AJ. et al. Semen Parameters Among Transgender Women With a History of Hormonal Treatment. Urology 2019; 124: 136-141
• 18 Barnard EP. et al. Fertility Preservation Outcomes in Adolescent and Young Adult Feminizing Transgender Patients. Pediatrics 2019; 144: e20183943
• 19 Schneider F. et al. Testicular Functions and Clinical Characterization of Patients with Gender Dysphoria (GD) Undergoing Sex Reassignment Surgery (SRS). J Sex Med 2015; 12: 2190-2000
• 20 Sinha A, Mei L, Ferrando C.. The effect of estrogen therapy on spermatogenesis in transgender women. F S Rep 2021; 2: 347-351
• 21 Peri A. et al. Predicting successful sperm retrieval in transfeminine adolescents after testicular biopsy. J Assist Reprod Genet 2021; 38: 2735-2743
• 22 Dilday EA. et al. Sperm Cryopreservation Outcomes in Transgender Adolescents Compared with Adolescents Receiving Gonadotoxic Therapy. Transgend Health 2022; 7: 528-532
• 23 Leung A. et al. Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine. Fertil Steril 2019; 112: 858-865
• 24 Adeleye AJ. et al. Ovarian stimulation for fertility preservation or family building in a cohort of transgender men. J Assist Reprod Genet 2019; 36: 2155-2161
• 25 Amir H. et al. Oocyte retrieval outcomes among adolescent transgender males. J Assist Reprod Genet 2020; 37: 1737-1744
• 26 Israeli T. et al. Similar fertilization rates and preimplantation embryo development among testosterone-treated transgender men and cisgender women. Reprod Biomed Online 2022; 45: 448-456
• 27 Amir H. et al. Ovarian stimulation outcomes among transgender men compared with fertile cisgender women. J Assist Reprod Genet 2020; 37: 2463-2472
• 28 Mattelin E, Strandell A, Bryman I.. Fertility preservation and fertility treatment in transgender adolescents and adults in a Swedish region, 2013-2018. Hum Reprod Open 2022; 2022: hoac008